Your browser doesn't support javascript.
loading
Systematic detection of m6A-modified transcripts at single-molecule and single-cell resolution.
Kim, Kyung Lock; van Galen, Peter; Hovestadt, Volker; Rahme, Gilbert J; Andreishcheva, Ekaterina N; Shinde, Abhijeet; Gaskell, Elizabeth; Jones, Daniel R; Shema, Efrat; Bernstein, Bradley E.
Affiliation
  • Kim KL; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  • van Galen P; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Hovestadt V; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Rahme GJ; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  • Andreishcheva EN; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Shinde A; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Gaskell E; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  • Jones DR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Shema E; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.
  • Bernstein BE; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Cell Rep Methods ; 1(5)2021 09 27.
Article in En | MEDLINE | ID: mdl-34734208
ABSTRACT
Epigenetic modifications control the stability and translation of mRNA molecules. Here, we present a microscopy-based platform for quantifying modified RNA molecules and for relating the modification patterns to single-cell phenotypes. We directly capture mRNAs from cell lysates on oligo-dT-coated coverslips, then visually detect and sequence individual m6A-immunolabled transcripts without amplification. Integration of a nanoscale device enabled us to isolate single cells on the platform, and thereby relate single-cell m6A modification states to gene expression signatures and cell surface markers. Application of the platform to MUTZ3 leukemia cells revealed a marked reduction in cellular m6A levels as CD34+ leukemic progenitors differentiate to CD14+ myeloid cells. We then coupled single-molecule m6A detection with fluorescence in situ hybridization (FISH) to relate mRNA and m6A levels of individual genes to single-cell phenotypes. This single-cell multi-modal assay suite can empower investigations of RNA modifications in rare populations and single cells.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: In Situ Hybridization, Fluorescence Type of study: Diagnostic_studies Language: En Journal: Cell Rep Methods Year: 2021 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: In Situ Hybridization, Fluorescence Type of study: Diagnostic_studies Language: En Journal: Cell Rep Methods Year: 2021 Document type: Article Affiliation country: Estados Unidos